Atlas FDA

WALLSTENT ENDOPROSTHESIS VENOUS

FDA premarket approval P980033/S032 · decided 2013-06-06

Approval details

PMA number
P980033
Supplement
S032
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
WALLSTENT ENDOPROSTHESIS VENOUS
Generic name
Stent, central venous
Applicant
Boston Scientific Corporation
Date received
2013-05-09
Decision date
2013-06-06
Days to decision
28 days
Decision code
OK30
Product code
QKJ
Advisory committee
Cardiovascular
Expedited review
No
Location
Maple Grove, MN
Statement
VENDOR LOCATION CHANGE.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
TheraSphere 360™ Y-90 Management Platform (K262462)Boston Scientific Corporation2026-07-24
FARADRIVE™ Steerable Sheath (M004PF21M402) (K262165)Boston Scientific Corporation2026-07-24
OBSIDIO Conformable Embolic (K261488)Boston Scientific Corporation2026-07-24
WallFlex Esophageal Stent System;Agile Esophageal Over-the-Wire (OTW) Stent System (K261978)Boston Scientific Corporation2026-07-10
RIVOS™ EUS Access Device (M00553900) (K260428)Boston Scientific Corporation2026-06-17
MOSES Raydar™ (K260100)Boston Scientific Corporation2026-05-18
TruSelect™ 2.6 Microcatheter (K260771)Boston Scientific Corporation2026-05-15
Asurys Fluid Management System (K251273)Boston Scientific Corporation2026-03-27